Big News: FounderDating is joining OneVest to build the largest community for entrepreneurs. Details here
Latest Notifications
You have no recent recommendations.
Name
Title
 
MiniBio
FOLLOW
Title
 Followers
FOLLOW TOPIC

Question goes here

1,300 Followers

  • Name
    Entrepreneur
  • Name
    Entrepreneur
  • Name
    Entrepreneur
  • Name
    Entrepreneur
  • Name
    Entrepreneur
  • Name
    Entrepreneur
  • Name
    Entrepreneur
  • Name
    Entrepreneur

Where do you think the circulating tumor cell market will be in the short, medium and long term?

Cancer research focused on circulating tumor cells has gained a lot of steam in the past 5 to 10 years. Most products are focused on isolation of these rare cells from blood with >30 products on the market focused solely on isolation. I am interested in getting this groups perspective on where this market will be heading.

6 Replies

Vijay Goel, MD
0
0
Vijay Goel, MD Entrepreneur • Advisor
Founder Chefalytics, Co-owner Bite Catering Couture, Independent consultant (ex-McKinsey)
My guess would be diagnostics marker first, biopsy substitute second, treatment vector 3rd (as any cocktail that eliminated metastatic spread should take out core tumor as well. Long road...and as in all things cancer, likely to face institutional resistance more than technical hurdles on the path to adoption.
Karl Schulmeisters
0
0
Karl Schulmeisters Entrepreneur
CTO ClearRoadmap

When you say "market" do you mean

  • Detection?
    • In Hospital
    • By mHealth device
  • Treatment?
    • Conventional,
    • advanced "personalized medicine"?

Each of these are different market segments and different investment types

Onikepe Adegbola, MD PhD
0
0
Global Head, Scientific Affairs, Clinical Trials at Quest Diagnostics
I remember the first time I heard the hype on CTCs, about 8 years ago, when I was in pharma and we were using it as an exploratory marker. Things have not moved much since then, as far as I can tell. It is still in the research mode, slowly moving into clinical use, but a number of barriers remain - standardization (what is a CTC? What is the best way to extract them? There are so many conflicting technologies, it is difficult to compare data), convincing clinical trial data, etc. In short I think it will remain mostly research in the short and medium term.
Here's a brief summary of the problems faced by a company in the space:http://lifescivc.com/2013/04/on-q-ity-a-cancer-diagnostic-company-r-i-p/
Maxine Pierson
0
0
Maxine Pierson Advisor
INTERIM CEO, EXECUTIVE DIRECTOR/ VP Investor
Dear Dr. Goel- As a mere layperson -A question if you please : As do I believe all tumors (exactly alike in totally different ways) have the same growth roadmap for self creation (vein system- etc) is there not a system of "road spikes " we can erect at the beginning to have a universal "stop sign -if you will?
Thank you very much.-Best Regards,

Maxine

Maxine Pierson
0
0
Maxine Pierson Advisor
INTERIM CEO, EXECUTIVE DIRECTOR/ VP Investor
As a layperson on the investor / educational/ delivery side - I believe we are only hampered by publicity and a national presence to provide funding; I am especially close to the gliablastoma problem; we need a Ted Kennedy / Bo Biden image /presence Foundation to be the figurehead.Most people do not know that clinical trial participation is not for the weak - or the poor .I was able to get an airline to provide free fare for trail participants and a caregiver- but it is a nightmare - financially and emotionally - and you are at best still rolling the dice ...Sorry to be so negative .
Joshua Falcon-Grey
0
0
Joshua Falcon-Grey Entrepreneur
Creative Leadership Trainer/Speaker and Immersive Media Developer
The industry will be changing rapidly at the mainstream starts to understand that cancer cures have been around for many years. It can be approached psychologically, supplementally, energetically - a variety of doorways. In essence, we all have out of control cancer cells that grow every single day and our immune system is designed to target and eliminate them. When our immune system is too weak, this cycle doesn't work properly. There's currently a docu-series circulating on this topic if you haven't seen it:thetruthaboutcancer.com/category/videos
Join FounderDating to participate in the discussion
Nothing gets posted to LinkedIn and your information will not be shared.

Just a few more details please.

DO: Start a discussion, share a resource, or ask a question related to entrepreneurship.
DON'T: Post about prohibited topics such as recruiting, cofounder wanted, check out my product
or feedback on the FD site (you can send this to us directly info@founderdating.com).
See the Community Code of Conduct for more details.

Title

Give your question or discussion topic a great title, make it catchy and succinct.

Details

Make sure what you're about to say is specific and relevant - you'll get better responses.

Topics

Tag your discussion so you get more relevant responses.

Question goes here

1,300 Followers

  • Name
    Details
  • Name
    Details
  • Name
    Details
  • Name
    Details
  • Name
    Details
  • Name
    Details
  • Name
    Details
  • Name
    Details
Know someone who should answer this question? Enter their email below
Stay current and follow these discussion topics?